Latebreakers: Transdermal option given OK for Parkinson's disease

Article

A unique delivery for a new dopamine agonist has been approved to treat symptoms of early Parkinson's disease (PD).

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Recent Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
© 2025 MJH Life Sciences

All rights reserved.